Introducing Doron Birger:

Doron Birger is a distinguished executive with a formidable background in the medtech sector, renowned for his exceptional leadership and strategic vision.

As the former chairman and director of Given Imaging (Nasdaq: GIVN; TASE: GIVN), where he played an instrumental role in its acquisition by Covidien (now Medtronic) for approximately USD 1 billion, Doron has showcased his unparalleled expertise in navigating high-stakes transactions and driving substantial value creation. Moreover, his tenure as CEO of Elron (Nasdaq: ELRNF; TASE: ELRN) further underscores his prowess in executive leadership and corporate governance.



Currently, Doron holds influential positions as Chairman of the Boards of Directors in several pioneering companies, including Medigus Ltd. (Nasdaq: MDGS), Sight Diagnostics, Intelicanna (TASE: INTL), Matricelf (TASE: MTLF), Icecure Medical (NASDAQ and TASE: ICCM), Kadimastem (TASE: KDST), Pluristem (NASDAQ and TASE: PSTI), and Hera Med. (ASX: HMD). His extensive portfolio of leadership roles highlights his commitment to fostering innovation and driving growth across various facets of the medtech landscape.

Doron’s impressive track record and unparalleled industry insights make him a tremendous addition to any team, offering a wealth of experience and strategic acumen that can significantly elevate organizational performance. We are honored to welcome Doron Birger aboard and eagerly anticipate the invaluable contributions he will undoubtedly make to our collective success.